Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacological treatment of psychotic depression

Trial Profile

Pharmacological treatment of psychotic depression

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Dec 2009

At a glance

  • Drugs Imipramine; Lithium; Quetiapine; Venlafaxine
  • Indications Psychotic affective disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Dec 2009 New source identified and integrated (Netherlands Trial Register, NTR26).
    • 01 Oct 2009 Results of phase 2 (lithium addition) published in the Journal of Clinical Psychopharmacology.
    • 06 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top